GGrantIndex
← Leaderboards

Jay Nelson

Oregon Health & Science University

$21,289,993
Attributed
$21,289,993
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.5M · FY201423
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$21,289,993 · 2

By mechanism

N01$21,289,993 · 2

Top collaborators

No co-investigators on record.

Most similar at Oregon Health & Science University

Same institution · by research overlap

Others in their field

Top investigators on “Pathogen

Research focus

PathogenLibrariesSmall MoleculeContractorHuman DiseaseAdjuvantSignal PathwayPharmaceutical ChemistryVaccinesCellsAnimal ModelZika VirusLead OptimizationDendritic CellsAntiviral AgentsComputer SimulationChikungunya VirusAntigensImmunologic AdjuvantsFlavivirusB-LymphocytesFda ApprovedHigh Throughput ScreeningEmerging Communicable Diseases

Grant awards (10)

Small-molecule activators of STING-signaling as novel adjuvants for flavivirus vaccines$2,104,354
N01 · FY2023 · AI · contact PI
Small-molecule activators of STING-signaling as novel adjuvants for flavivirus vaccines$2,267,043
N01 · FY2022 · AI · contact PI
Small-molecule activators of STING-signaling as novel adjuvants for flavivirus vaccines$2,090,420
N01 · FY2021 · AI · contact PI
Small-molecule activators of STING-signaling as novel adjuvants for flavivirus vaccines$2,202,887
N01 · FY2020 · AI · contact PI
Small-molecule activators of STING-signaling as novel adjuvants for flavivirus vaccines$2,061,192
N01 · FY2019 · AI · contact PI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, Zika and Japanese Encephalitis Virus vaccines$1,668,139
N01 · FY2018 · AI · contact PI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, Zika and Japanese Encephalitis Virus vaccines$2,513,447
N01 · FY2017 · AI · contact PI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus vaccines$2,338,653
N01 · FY2016 · AI · contact PI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus vaccines$2,035,489
N01 · FY2015 · AI · contact PI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus vaccines$2,008,369
N01 · FY2014 · AI · contact PI